BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2159595)

  • 1. Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase.
    Méry PF; Brechler V; Pavoine C; Pecker F; Fischmeister R
    Nature; 1990 May; 345(6271):158-61. PubMed ID: 2159595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
    Yu HJ; Ma H; Green RD
    Mol Pharmacol; 1993 Oct; 44(4):689-93. PubMed ID: 7694067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells.
    Fischmeister R; Hartzell HC
    Mol Pharmacol; 1990 Sep; 38(3):426-33. PubMed ID: 1698253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2 adrenergic activation of L-type Ca++ current in cardiac myocytes.
    Skeberdis VA; Jurevicius J; Fischmeister aR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):452-61. PubMed ID: 9353357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of cardiac calcium current by cGMP/NO route].
    Fischmeister R; Méry PF
    C R Seances Soc Biol Fil; 1996; 190(2-3):181-206. PubMed ID: 8869231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.
    Hartzell HC; Fischmeister R
    Nature; 1986 Sep 18-24; 323(6085):273-5. PubMed ID: 2429189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.
    Rivet-Bastide M; Vandecasteele G; Hatem S; Verde I; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1997 Jun; 99(11):2710-8. PubMed ID: 9169501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of three guanylyl cyclase inhibitors on the L-type Ca2+ and muscarinic K+ currents in frog cardiac myocytes.
    Abi-Gerges N; Hove-Madsen L; Fischmeister R; Méry PF
    Br J Pharmacol; 1997 Aug; 121(7):1369-77. PubMed ID: 9257916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.
    Wildenthal K; Allen DO; Karlsson J; Wakeland JR; Clark CM
    J Clin Invest; 1976 Mar; 57(3):551-8. PubMed ID: 175087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein.
    Brechler V; Pavoine C; Hanf R; Garbarz E; Fischmeister R; Pecker F
    J Biol Chem; 1992 Aug; 267(22):15496-501. PubMed ID: 1353495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of forskolin and acetylcholine on calcium current in single isolated cardiac myocytes.
    Hartzell HC; Fischmeister R
    Mol Pharmacol; 1987 Nov; 32(5):639-45. PubMed ID: 2446114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
    Fischmeister R; Castro L; Abi-Gerges A; Rochais F; Vandecasteele G
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):136-43. PubMed ID: 15927494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C.
    Refsnes M; Dajani OF; Sandnes D; Thoresen GH; Røttingen JA; Iversen JG; Christoffersen T
    J Cell Physiol; 1995 Sep; 164(3):465-73. PubMed ID: 7650056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA inhibition of cyclic AMP production in immortalized GnRH neurons is mediated by calcineurin-dependent dephosphorylation of adenylyl cyclase 9.
    Martin C; Jacobi JS; Nava G; Jeziorski MC; Clapp C; Martínez de la Escalera G
    Neuroendocrinology; 2007; 85(4):257-66. PubMed ID: 17551263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cyclic AMP signaling system in rat aortic myocytes in primary culture and aorta.
    Schoeffter P; Lugnier C; Travo C; Stoclet JC
    Lab Invest; 1989 Aug; 61(2):177-82. PubMed ID: 2474090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-independent activation of cardiac adenylyl cyclase by GDP and membrane-associated nucleoside diphosphate kinase. A new cardiotonic mechanism?
    Niroomand F; Mura R; Jakobs KH; Rauch B; Kübler W
    J Mol Cell Cardiol; 1997 May; 29(5):1479-86. PubMed ID: 9201632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.